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Dengue is a major international public
health concern and one of the most
important arthropod-borne diseases [1].
Approximately 2.5 billion people—40% of
the world’s population, in over 100
countries—are at risk of dengue virus
(DENV) infection [2]. In recent years the
average annual incidence of dengue-relat-
ed serious disease in many tropical coun-
ties has been rising dramatically, with the
infection becoming endemic in areas
where its occurrence was once sporadic
[3].
The exponential increase over the last
decade has been connected to societal
changes, such as population growth and
increasing urbanization [4]. In addition, it
has been suggested that rising tempera-
tures and global climate change may lead
to the expansion of the range of major
mosquito vectors into new areas, extension
of the transmission season in current
endemic areas, and increase in the mos-
quito species vectorial capacity [5–7].
Human migration (likely including infect-
ed hosts) and international travel are
constantly introducing new vectors and
pathogens into novel geographic areas [8].
For example, chikungunya virus was
introduced into northeastern Italy in
2007, causing an outbreak with local
transmission due to the presence of Aedes
albopictus, a vector also capable of trans-
mitting dengue virus [9]. In 2010, three
authochthonous cases of dengue were
reported in Europe, thereby highlighting
the potential for global spread of this
disease [10,11]. The island of Madeira,
where the mosquito vector Aedes aegypti is
present, experienced a major dengue
outbreak in the fall of 2012 [12], high-
lighting that the introduction of dengue to
non-endemic areas is a real threat.
Dengue has been neglected for many
years. Major research gaps for dengue
exist in the areas of epidemiology under
changing climate conditions, clinical man-
agement, pathogenesis, vector control,
surveillance and response, vaccines, drugs,
and health policy research [13].
The European Commission (EC)
launched a call under the Seventh Frame-
work Programme with the title of ‘‘Com-
prehensive control of Dengue fever under
changing climatic conditions’’ (http://ec.
europa.eu/research/participants/portal/page/
cooperation?callIdentifier = FP7-HEALTH
-2011-single-stage). The focus of this call
is summarized in Box 1. Within this
framework, in 2011, the EC awarded a
total of approximately J18 million to
three consortia. The hosting institutions
are Heidelberg University Hospital (Ger-
many), the Institute Pasteur (Paris,
France), and Umea˚ University (Sweden).
Each consortium has partners from
countries with endemic and epidemic
dengue. In total, the consortia comprise
38 partners from 21 countries, of which
11 are from Asia and Latin America, the
current hotspots of dengue endemicity,
and one from Africa (Figure 1).
The funding of such a large and
complex research programme focusing
on a single disease highlights the emphasis
that the European Commission has put on
dengue and its potential threat to Europe.
In this paper, we present these
three consortia and outline their scientific
strategies and potential role within the
international dengue research community.
I. International Research




Differentiating dengue from other com-
mon febrile illnesses before complications
develop is difficult; simple and inexpensive
strategies are urgently needed to support
early and accurate diagnosis, as well as to
identify patients at high risk of developing
complications. Similarly, characterisation
of the profiles of important viral and
serological biomarkers is likely to provide
valuable information that could contribute
to diagnostic and prognostic algorithms.
However, if the fight to gain control of
the current global pandemic is to be
successful it is equally important to
consider interventions and strategies at
the population level. Early detection of
outbreaks, with improved surveillance
systems and a prompt response to immi-
nent outbreaks, could prove highly effec-
tive in reducing the numbers of dengue
cases globally. In combination with iden-
tification of areas likely to be at risk of
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dengue outbreaks, as defined by risk
mapping, such strategies could bring great
health benefits.
Description of Work Packages
The overall objectives of IDAMS are
organized into six work packages (WP),
grouped in two areas:
(1) Improving clinical management and
diagnosis of dengue (WP 1 & 2)
(2) Assessing the risk of dengue spread
(WP 3 & 4)
WP 5 & 6 are translational or admin-
istrative in character (Figure 2). In WP 1, a
large prospective multicentre study has
been designed aiming to improve the
ability to distinguish dengue from other
febrile illnesses in the early phase of
disease, and to develop better prognostic
markers or warning signs that predict the
need for closer monitoring/hospitalisation,
or are associated with development of
severe disease. In addition, the clinical
data will be used to assess the performance
of the 2009 WHO classification in prac-
tice, and to inform the development of a
more effective approach to dengue within
the Integrated Management of Childhood
Illness (IMCI) guidelines [14]. The pro-
spective multicentre study is carried out in
Vietnam, Cambodia, Malaysia, Indonesia,
Brazil, Venezuela, and El Salvador.
The virological and immunological
research in WP 2 builds on the infra-
structure of the prospective clinical study
with the intention of identifying virolog-
ical, immunological, and host genetic
variables associated with severe outcomes,
and assessing their practical utility as
prognostic markers. A novel approach to
dengue vaccine development will also be
explored via the generation of a T cell
vaccine.
WP 3 will develop new country-specific
models for early detection of dengue
outbreaks together with better response
mechanisms to minimise the consequences
of such outbreaks; the best existing strat-
egies will be employed alongside proven
novel approaches and tools to effect these
ends.
The mapping in WP 4 has two main
aims: first, to develop a contemporary
dengue occurrence map at the global scale
[15]; and second, to investigate the
potential impact of environmental change
on this distribution and provide occur-
rence maps for 2020, 2050, and 2080.
WP 5 has an overarching role in
IDAMS, providing a platform for net-
working and translational activities within
the entire research programme by coordi-
nating the input from network partners
operating on a regional to global scale in
the control of dengue (e.g., the Special
Programme for Research and Training in
Tropical Diseases of the World Health
Organization [WHO-TDR]; the Red
Cross/Red Crescent Climate Centre
[RCCC]; the International Network for
the Demographic Evaluation of Popula-
tions and Their Health [INDEPTH]; and
the European Center for Disease Control
[ECDC]). Part of this work will involve
developing a research framework for
dengue in Africa.
II. Dengue Research Framework
for Resisting Epidemics in
Europe (DENFREE)
Rationale and Hypotheses
Epidemiological studies have suggested
that most dengue viral infections are
subclinical or pauci-symptomatic—at least
for primary dengue viral infections [16–
18]. This means that in a completely naı¨ve
population, the first cases in hospitals will
be the tip of the iceberg. Thus hospital-
based surveillance is inadequate—too little
and too late. Inherent in the DENFREE
programme is the hypothesis that im-
proved surveillance and diagnosis of the
pauci-symptomatic dengue viraemic indi-
viduals will contribute to effective inter-
vention. Active surveillance programmes
to detect symptomatic infections include
school-based absenteeism and community
(door-to-door) approaches [19]. Neither of
these approaches will be realistic or
necessarily useful under an invasion sce-
nario in Europe where the force of
infection will be initially small. Whilst a
programme of active surveillance would
be ideal to detect completely subclinical
infections, based on, for example, cluster
analyses around index cases, this is not a
realistic option and assumes dengue trans-
mission is largely household based. Al-
though there is good evidence that
household transmission can occur, this
is not always the case, as shown in Brazil
[20] and suggested for the changing
epidemiology of dengue in Singapore
[21]. In Brazil, dengue cases clustered
around places of high human movement
and contact (e.g., markets). In Singapore,
the effective intra-domiciliary vector con-
trol programmes reduced the importance
of household transmission, but have
remained ineffective at controlling overall
dengue incidence, likely because of
transmission hotspots in public places,
including schools. Given the high level of
access to health care in Europe, individ-
uals with only very mild fever or other
symptoms (pauci-symptomatic) are likely
to present to their assigned General
Practitioner (GP). Equipping a network
of GPs with a simple diagnostic kit that
can detect the virus even in pauci-
symptomatic infections would provide a
passive surveillance programme that can
extend the detection of dengue infections
beyond the more serious cases presenting
at hospitals.
Box 1. European Commission Seventh Framework Programme
FP7 Cooperation - Health
HEALTH.2011.2.3.3-2: Comprehensive control of Dengue fever under
changing climatic conditions. FP7-HEALTH-2011-single-stage. Research
should develop innovative tools for one or more of the following aspects: better
diagnosis, surveillance, development of treatment, prevention and vaccination
strategies, prevention, and/or prediction and prevention of the spread of dengue
fever to previously uninfected regions (including Europe), in the context of
climate change. Research may also include studies on the underlying
pathogenesis with respect to viral and host factors that can predict disease
severity and prepare for further development of new vaccines, antiviral
compounds, and more targeted treatment schemes.
Funding Scheme Specific International Cooperation Action (SICA) Collaborative
Project (small- or medium-scale focused research project) target regions: Latin
America and/or Asia. SICA aims to bring about the balanced participation of third
countries in collaboration with European partners.
Expected Impact Better tools, and the use thereof, for improved comprehensive
control of dengue fever at a global level. Participation from both SICA target
regions and Small and Medium Enterprises SMEs in the projects should help
ensure innovation and exploitation of the results in this area/topic. The degree of
such participation will be considered during the evaluation.
Source: http://ec.europa.eu/research/health/infectious-diseases/emerging-epidemics/
call-for-proposals_en.html
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Description of Work Packages
The work programme is broken down
into nine work packages with one work
package (WP 9) dedicated to consortium
management, assessment of progress, and
dissemination of the results (Figure 3).
WP 1 (Index case community study of
the epidemiology of dengue) is a central
WP, which will provide data and biolog-
ical samples to other WPs. They will
characterize local dengue virus (DENV)
transmission patterns through cluster anal-
yses [22], identify subclinical infections for
mosquito transmission studies (WP 5
entomology), by direct and indirect feed-
ing to laboratory-reared mosquitoes, es-
tablish empirical mosquito, human densi-
ty, and geo-spatial data for use in fine-scale
and agent-based simulation models (WP 3
climate prediction and WP 4 epidemio-
logical models), establish a biobank of
biological samples from patients, house-
hold members and mosquito vectors for
further study in other WPs (WP 2
diagnostics, WP 6 virology, WP 7 immu-
nology, and WP 8 human genetics), and
test novel diagnostic and prognostic tools
developed by WP 2 in retrospective
samples and prospective recruited cohorts
in Cambodia and Thailand.
III. Innovative Tools and
Strategies for the Surveillance
and Control of Dengue
(DengueTools)
Rationale and Hypotheses
We lack good understanding of
individual or combined roles of viral,
Figure 1. The world map of the three EU-funded dengue consortia. IDAMS: UKL-HD: Heidelberg University Hospital, Germany (Coordinator);
UOXF.AT: Oxford University, UK; OUCRU: Oxford University Clinical Research Unit, Vietnam; LSTM: Liverpool School of Tropical Medicine, UK; IRB: Fondazione
per l’Istituto di Ricerca in Biomedicina, Switzerland; WHO: World Health Organization - Special Programme for Training and Research in Tropical Diseases,
Switzerland/Int. Partner; UMAL: University of Malaya Medical Center, Malaysia; UGM: University Gadjah Madah, Indonesia; AHC: Friends without a Border -
Angkor Hospital for Children, Cambodia; IPK: Institute Of Tropical Medicine ‘‘Pedro Kouri’’, Cuba; HNNBB: Ministry of Health - Hospital National de Ninos
Benjamin Bloom, El Salvador; UECE: Fundacao Universidade Estadual do Ceara, Brazil; ERGO: Environmental Research Group Oxford Limited, UK; INDEPTH:
INDEPTH-Network, Ghana; RCCC: Red Cross/Red Crescent Climate Centre, Netherlands; UC: University of Carabobo, Venezuela; FIOCRUZ: Fundacao Oswaldo
Cruz, Brazil. DENFREE: IPP: Institut Pasteur, France (Coordinator); IMPERIAL COLLEGE: Imperial College, UK; BNI-HAMBURG: Bernard Nocht Institute,
Germany; MAH: Mahidol University, Thailand; IPC: Institut Pasteur, Cambodia; IC3: Fundacio Institut Catala De Ciencies Del Clima, Spain; UROUEN: University
Of Rouen, France; CNRS: Centre Nationale de la Re´cherche Scientifique, France; FFCUL: Cmaf, Fundacao Da Faculdade De Ciencias Da Universidade De Lisboa,
Portugal; IPATIMUP: Instituto De Patologia E Imunologia Molecular Da Universidade Do Porto, Portugal; BCP: Biocomputing Platforms Ltd. Oy, Finland;
AMPTEC: Amptec Ltd., Germany; RIOTECH: Riotech Pharmaceticals Ltd., UK; IPK: Institute Of Tropical Medicine ‘‘Pedro Kouri’’, Cuba. DENGUETOOLS: UmU:
Umea University, Sweden (Coordinator); SRL: Epidemiological Unit, Ministry of Health, Sri Lanka; TDX: TwistDx Ltd., Cambridge, UK; UMAL: University of
Malaya, Malaysia; OXTC: Oxited Ltd., Oxford, UK; MAH: Mahidol University, Thailand; LSTMH: London School of Hygiene and Tropical Medicine, UK; STPH:
Swiss Tropical and Public Health Institute, Switzerland; IPP: Institut Pasteur, France; UKL-HD: Heidelberg University Hospital, Germany; DKNS: Duke-NUS
Graduate Medical School Singapore; USP: University of Sa˜o Paulo, Brazil; ISCIII : Instituto de Salud Carlos III, Spain; EID: Entente Inter-De´partementale pour la
De´moustication du littoral me´diterrane´en, France. The two partners University of Carabobo (UC, Venezuela) and Fundacao Oswaldo Cruz (FIOCRUZ, Brazil)
have been recently accepted to the IDAMS consortium. The amendment request submitted for approval to the European Commission is on-going.
doi:10.1371/journal.pntd.0002320.g001
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entomological, ecological, environmental,
and climate factors that influence dengue
transmission dynamics and their respective
outbreak predictive capability and the
most cost-effective approach for surveil-
lance and early warning systems. For
surveillance to effectively provide early
warning for epidemic transmission, it must
be active, laboratory-based, and compre-
hensive in its coverage of the spectrum of
clinical illness and the factors that influ-
ence transmission dynamics. Several po-
tential predictive indicators for outbreaks
have been described but require further
study [23,24]. Early diagnostic assays at
point-of-care that are affordable and can
be used in the field are also missing.
Vector surveillance in particular has many
shortcomings, specifically the lack of
sensitive, reliable, and simple field meth-
ods for vector surveillance.
Furthermore, in many endemic coun-
tries, children are the most affected group,
in terms of both incidence and severity of
dengue. Effective control strategies to
protect children are lacking—in particu-
lar, simple, cost-effective, and scalable
strategies. Children spend a substantial
amount of their time at schools, and Aedes
mosquitoes bite mainly during the day.
Although transmission is reported to occur
at the household level, there is also
increasing evidence that schools may
contribute to transmission [25].
We hypothesize that insecticide-treated
school uniforms may be a target for a
school-based intervention to reduce the
incidence of dengue in school children
[26], and propose to test this hypothesis
under laboratory and field conditions.
Lastly, the risk of introduction of dengue
to non-infected areas, including Europe,
needs to be explored in more detail in order
to enhance Europe’s preparedness for the
potential emergence of dengue. We cur-
rently have insufficient data on the magni-
tude and trends of importation and virus
evolution over time and by geographic
origin. We also only have a poor under-
standing of vector density, preferred breed-
ing sites, and vectorial capacity of Aedes in
temperate climates that are needed for
predictive models under changing climate
conditions.
Figure 2. Structure of the work packages (WP) of the IDAMS consortium. The core of the IDAMS project focuses on parallel strategies aimed
at: (1) Improving diagnosis and clinical management of dengue through two linked work packages designed a) to identify readily available clinical
and laboratory parameters and/or viral and immunological markers that differentiate between dengue and other common febrile illness within three
days of fever onset, and b) to identify any of the available markers that are predictive of the likelihood of evolving to a more severe disease course. (2)
Assessing the risk of dengue spread though linked work packages focused on a) mapping and modeling techniques to define the current extent of
dengue disease globally and to evaluate possible scenarios of spread or risk to previously uninfected regions in the future, and b) developing
effective and affordable early warning and outbreak response systems. These four work packages are supported by a fifth work package dedicated to
networking and translational activities to ensure that outputs from the various research activities are used to maximal advantage. A sixth work
package will focus on administrative issues.
doi:10.1371/journal.pntd.0002320.g002
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Description of Work Packages
The DengueTools consortium research
strategy has been described in more detail
elsewhere [27]. In summary DengueTools
has developed three research areas to
address the above outlined gaps related
to (1) surveillance, (2) prevention, and (3)
risk of introduction to uninfected areas.
DengueTools consists of 12 work pack-
ages around these three research areas
(Figure 4).
Research area one with three work
packages focuses on surveillance with the
objective to develop a comprehensive
early warning and surveillance system that
has predictive capability for epidemic
dengue and benefits from novel tools for
laboratory diagnosis and vector monitor-
ing. WP 1 plans to set up a comprehensive,
early warning, laboratory-based sentinel
disease surveillance system in Sri Lanka.
This prospective study will use an integrat-
ed surveillance system that incorporates a
set of indicators that include clinical,
epidemiologic, virologic, entomologic, me-
teorologic/climate, environmental, and so-
cio-economic data. The intent is to identify
factors, or a combination of factors, that
most sensitively predict epidemic dengue.
WP 2, based in Kuala Lumpur, Malaysia,
partnering with TwistDx in Cambridge,
UK, has set out to develop two novel
approaches for a point-of-care early diag-
nostic assay that can potentially be used in
field conditions and surveillance systems.
Oxitec in Oxford, UK, is responsible for
WP 3, which will evaluate novel approach-
es to vector surveillance.
Research area 2 with two work packages,
focuses on the prevention of dengue in
school children using insect repellent–im-
pregnated school uniforms. Partners in WP
4 will conduct a school-based randomized
controlled trial in ten schools in Chochaeng-
sao Province, Thailand. The trial protocol is
publicly available [28]. To complement this
trial, we will also conduct laboratory-based
studies on impregnated school uniforms at
Figure 3. Structure of the work packages (WP) of the DENFREE consortium. For the DENFREE project work package (WP) 1 (Index case
community study of the epidemiology of dengue) is a central WP, which will provide data and biological samples for other WPs. This WP is a
multicentric, prospective study in Cambodia and Thailand, which will characterize local DENV transmission patterns, identify subclinical infections for
mosquito transmission studies (WP5 entomology), establish empirical mosquito, human density, and geo-spatial data for use in fine-scale and agent-
based simulation models (WP3 climate prediction and WP4 epidemiological models), establish a biobank of biological samples from patients,
household members, and mosquito vectors for further study in other WPs (WP2 diagnostics, WP6 virology, WP7 immunology, and WP8 human
genetics), and test novel diagnostic and prognostic tools developed by WP2. Contributions from each WP will bring complementary help to the
consortium to achieve the main aims. WP2 will develop new point-of-care diagnostic tools that can be used in the community to screen subclinical
individuals in epidemic regions and to test for DENV in mosquito samples, thereby validating a new mosquito trap tool developed by WP5. WP3 and
WP4, by using better surveillance data, will help determine the underlying factors, extent, and course of a DENV epidemic. Altogether, we will provide
a new strategy for dengue surveillance for better control of DENV transmission.
doi:10.1371/journal.pntd.0002320.g003
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the London School of Hygiene & Tropical
Medicine (WP 5).
Research area 3 with another three work
packages focuses on the risk of introduction
of dengue into currently non-endemic areas.
WP 6 will collect clinical and virological data
in travelers returning to Europe from
dengue-endemic countries. WP 7 has set
out to explore the role of Aedes albopictus in
southern France, but will also investigate
control strategies of Aedes albopictus in
Europe. WP 8 will work on predictive risk
modeling and maps under different future
climate scenarios in Europe.
Cross-cutting work packages were add-
ed with skills and expertise in research
conduct and data management (WP 9),
geo-spatial modeling and risk maps (WP
10), and economic evaluation and evi-
dence-informed policy making (WP 11),
mainly contributing to WP 1 and WP 4,
but also to other work packages if needed.
Lastly, WP 12 is responsible for man-
agement and dissemination of the scientif-
ic results.
Summary and Outlook
To respond to the call under the
Seventh Framework Programme with the
title of ‘‘Comprehensive control of Dengue
fever under changing climatic conditions,’’
each of the three consortia developed
programmes that address many of the
major research gaps as identified by the
European Commission (Box 1). Box 2 lists
the deliverables that each of the consortia
has set out to achieve.
The three consortia each have a
different focus—but in some aspects also
common themes. Table 1 summarizes the
commonalities and differences.
All three consortia propose to use an
evidence-based multidisciplinary approach
to identify the key combinations of factors
predictive of dengue outbreaks in endemic
settings. The common objective is to
identify innovative tools, develop new
strategies for dengue surveillance for early
detection and effective response to the
threat of outbreaks, and develop dengue
risk maps on a global scale.
Maps can be powerful tools for advo-
cacy, but have also been proven useful to
investigate the equity and adequacy of
international financing—e.g., in the case
of malaria control [29]. IDAMS will
undertake a global mapping programme
to address the true extent of the global
distribution of dengue in order to provide
a basis upon which future risk and burden
of disease can be addressed [30]. This
includes prediction and prevention of the
spread of dengue fever to previously
uninfected areas—an area also of impor-
tance for DengueTools. DengueTools
places particular emphasis on dengue risk
maps under different climate and future
scenarios, influenced by global human
mobility. DENFREE places more empha-
sis on the transmissibility of the virus
according to the clinical state of the
infected human (i.e., subclinical vs. symp-
tomatic) and the vector–virus genetic
constitution.
To address research questions around
the evolving epidemiology of dengue, the
Figure 4. Structure of the work packages (WP) of the DengueTools consortium. The DengueTools project is comprised of 12 work
packages around the following three research areas: Research area 1: Develop a comprehensive early warning and surveillance system that has
predictive capability for epidemic dengue and benefits from novel tools for laboratory diagnosis and vector monitoring. Research area 2: Develop
novel strategies to prevent dengue in children. Research area 3: Understand and predict the risk of global spread of dengue, in particular the risk of
introduction and establishment in Europe, within the context of parameters of vector competence, global mobility, and climate change.
doi:10.1371/journal.pntd.0002320.g004
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Box 2. Deliverables of the Three European Commission-Funded Dengue Research Consortia
I. International Research Consortium on Dengue Risk Assessment, Management, and Surveillance (IDAMS):
N Development of study Case Report Form (CRF) and initiation of study at first site
N Development of centralised computer database for local data entry at each site
N Recruitment of 50% of sample size with data entry completed
N Evaluation report on warning signs and on the practical application of the 2009 WHO dengue case classification scheme,
compared with the DHF/DSS classification scheme
N Molecular diagnosis of dengue patients underway
N Serological assays optimised and characterised
N Characterization of the immunogenicity of novel vaccine constructs
N Identification of reliable, sensitive, practical epidemiological indicators
N Recommendations for outbreak response tools for effective vector control tools
N Recommendations for outbreak response plans for health care service reorganisation
N Integrated Surveillance Model
N Contemporary/baseline map of dengue occurrence
N Future map of dengue occurrence (2020, 2050, and 2080)
N Consensus documents on (1) research process and (2) policy recommendations
N Policy briefs on the organisation of dengue surveillance
N Documented quality assurance in all WPs
II. Dengue Research Framework for Resisting Epidemics in Europe (DENFREE)
N Evaluate the impact of climate on the incidence of disease in Southeast Asia
N Develop dynamical models that incorporate both short-term protective cross-immunity and longer term antibody-dependent
enhancement to explain the incidence of dengue observed in Thailand over the last 30 years
N Integrate a dynamic disease model within a seamless ensemble prediction system and assess the extent to which climate-
variable forecasting can usefully explain dengue incidence
N Develop real-time agent based models pinpointing key factors determining dengue diffusion at the very local scale
N Estimate proportion of inapparent dengue viral infections that result in mosquito transmission
N Evaluate vector competence in European mosquito species
N Evaluate an alternative tool to reduce dengue risk at pauci-symptomatic dengue viremic carriers
N Identify viral genetic markers correlating with subclinical/symptomatic infection
N Identify viral genetic markers associated with enhanced transmission by the European mosquito Aedes albopictus
N Perform a comparative analysis of the immunological response (B cell, T cell, and cytokine) to infections that have lead to
subclinical and symptomatic infections
N Evaluate role of human immune-related genes in the outcome of dengue viral infection
N Evaluate new anti-dengue viral compounds: pharmacokinetics, toxicities, and activity against dengue replication and
immunological consequences in vivo in mouse models
N Develop an ultra-sensitive tool to detect virus
N Develop a simple and rapid test for detection of DENV antibodies on a dipstick platform
N Develop a test for detection of DENV specific immune responses on an antigen array platform
III. Innovative Tools and Strategies for the Surveillance and Control of Dengue (DengueTools)
N Develop and validate novel diagnostic assays for point-of-care use
N Field-test novel diagnostic assays
N Develop novel field devices and attractants for vector monitoring
N Develop novel assays for virus detection and characterisation in Aedes mosquitoes
N Develop geospatial modeling and risk maps
N Develop a comprehensive, early warning, laboratory-based sentinel disease surveillance system
N Study viral genomic sequence data and the potential role in causing outbreaks of more severe disease
N Evaluate an integrated surveillance system and identification of the most useful and cost-effective outbreak predictive factors,
or the combination thereof
N Develop early warning predictive models, in particular signature forecasting and a flagging system
N Engage policymakers on the sustainability of an integrated surveillance system
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approaches of the three consortia are quite
different: While IDAMS uses comparative
country studies based on existing data and
consultation of expert committees, then
performs prospective evaluation of the
improved model in key locations, DEN-
FREE implements a community-based
approach, with emphasis on studying the
spread of dengue at the local scale,
examining the importance of micro-scale
environmental parameters on dengue ep-
idemiology and addressing the extent and
epidemiological importance of pauci-
symptomatic and/or subclinical infections.
DengueTools implements a prospective
study design to better determine the most
appropriate and cost-effective dengue
surveillance system using a comprehen-
sive, active, laboratory-based approach.
Also in areas other than mapping, the
consortia have outlined similar or comple-
mentary research objectives. Both IDAMS
and DENFREE will investigate methods
for risk factors and markers that may
predict the development of more severe
disease, which would be important infor-
mation for better clinical case manage-
ment at the individual patient level. For
clinical, virological, and host factors pre-
dicting disease severity, IDAMS focuses
on a large cohort study in outpatient
facilities and hospitals around the world
in order to identify factors associated with
the development of severe disease. DEN-
FREE plans to collect information of
dengue in the community, ranging from
subclinical infection to clinical dengue.
DengueTools plans to look at clinical and
virological parameters that may contribute
to improved surveillance systems.
Both DENFREE and DengueTools pro-
pose to develop a point-of-care dengue
diagnostic test and novel tools for vector
monitoring. In addition, DengueTools will
conduct a community-based intervention
trial to investigate a novel approach to
prevent dengue in school children by using
insect repellent-impregnated school uniforms.
Despite the different research strategies
of the three EU-funded consortia, some
similar approaches allow for collaborative
efforts. Supported by the EC, the three
consortia met in April 2012 in order to
discuss synergies and a common agenda.
As a result of this meeting, the three EC-
funded consortia will collaborate on a
global risk map for dengue to enhance
dengue control and facilitate the commu-
nication about the continuing threat of
dengue spreading to previously uninfected
areas.
In conclusion, dengue is currently high
on the political agenda of many endemic
areas, particularly of those countries that
have experienced a recent dramatic rise in
incidence. Funding of three dengue-fo-
cused consortia by the European Com-
mission also highlights Europe’s interest in
this disease. The three publicly funded
N Determine the protection efficacy of school uniforms impregnated with repellent under different laboratory scenarios
N Determine the efficacy of impregnated school uniforms on the reduction of dengue incidence in school-aged children
N Develop a cost-effectiveness framework and model for the school-based preventive intervention
N Produce policy briefs to ensure the scalability of such school intervention programmes
N Describe the trends of dengue importation into Europe
N Produce phylogenetic trees and Bayesian modeling on dengue viruses imported to Europe
N Identify typical breeding sites for Ae. albopictus in southern France
N Evaluate the impact of ultra-low volume (ULV) aerosols on the abundance of Ae. albopictus in southern France
N Estimate values for the parameters of vectorial capacity
N Develop predictive models that integrate vectorial capacity to assess the risk of establishment of dengue following
introduction of the virus
Table 1. Overlap and complementarity of research areas between the three EU-funded dengue consortia.
Research areas IDAMS DengueTools DENFREE
Assessing the risk of dengue spread WP3, WP4
Geo-spatial modeling and risk maps WP4 WP 10
Innovative tools for prediction and prevention of dengue spread WP3, WP4, WP5
Risk of introduction to uninfected regions WP6, WP7, WP8
Surveillance WP3 WP1, WP2, WP3, WP6 WP2, WP5
Prevention WP3 WP4, WP5
Improving clinical management and diagnosis WP1, WP2 WP1 WP1
Diagnostic tools WP1, WP2 WP2 WP2
Virology WP2 WP6
Immunology WP2 WP7
Human genetics/mouse model WP2 WP8
Economic evaluation WP4 WP11
Evidence-informed policy making WP3 WP11
Networking and translational activities WP5 WP12
Research conduct, data management and modeling WP1 WP9
Management WP6 WP12 WP9
doi:10.1371/journal.pntd.0002320.t001
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dengue research consortia present a
unique opportunity to address the threat
of dengue in endemic countries, but also to
Europe. It will be important for these
consortia to reach out to the global players
in the international scientific dengue
community. It is equally important for
existing international and national dengue
research groups to engage with newer
dengue research groups such as these three
EU-funded consortia. One example for a
platform to enhance international scientif-
ic networking and exchange is the Global
Health Network. The Global Health
Network is a collection of websites that
aim to support research by sharing
knowledge and methods (http://tghn.
org/). The ultimate aim is to build
collaborations, share resources, and ex-
change information.
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